Literature DB >> 2827829

Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS.

J A Gray1, G M Goodwin, D J Heal, A R Green.   

Abstract

1 Intraperitoneal injection to mice of the gamma-aminobutyric acidB (GABAB) receptor agonist (+/-)-baclofen induces a dose-dependent decrease in rectal temperature. 2 Injection of (-)-baclofen intracerebroventricularly at doses that had no effect when given peripherally induced a marked hypothermia. (+)-Baclofen was without effect. 3 The decrease in rectal temperature induced by (-)-baclofen when injected intraperitoneally was highly correlated with an increase in sedation. 4 Repeated administration of amitriptyline (10 mg kg-1 daily for 14 days) resulted in mice displaying an enhanced temperature and sedation response to injection of (+/-)-baclofen (5 mg kg-1) 24 h after the last dose of antidepressant. 5 An enhanced hypothermic response was also seen following repeated administration of zimeldine, mianserin or desipramine (all 10 mg kg-1 daily for 14 days) or repeated electroconvulsive shock (ECS; 5 ECS over 10 days) 24 h after the last treatment. 6 A single administration of any of the antidepressant drugs or ECS or repeated administration of the anxiolytic drug flurazepam (20 mg kg-1 daily for 14 days) did not alter the baclofen-induced hypothermic response. 7 Administration of (+/-)-baclofen (5 mg kg-1) daily for 5 or 14 days attenuated the baclofen-induced hypothermic response. However, one pretreatment dose did not alter the response. 8 It has previously been reported that repeated baclofen administration decreases GABAB receptor number in the brain while repeated administration of antidepressant drugs and ECS increases the density of this receptor. The current data therefore suggest that baclofen-induced hypothermia may provide a simple index of GABAB receptor function in the brain and strengthens the evidence that GABAB receptor function is enhanced by antidepressant drugs and ECS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827829      PMCID: PMC1853729          DOI: 10.1111/j.1476-5381.1987.tb11392.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks.

Authors:  J A Gray; A R Green
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

2.  Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.

Authors:  A R Green; D J Heal; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

3.  Synaptic pharmacology of barbiturates and benzodiazepines.

Authors:  W E Haefely
Journal:  Agents Actions       Date:  1977-09

4.  Interactions between clonidine and antidepressant drugs: a method for identifying antidepressant-like agents.

Authors:  P F Von Voigtlander; H J Triezenberg; E G Losey
Journal:  Neuropharmacology       Date:  1978-06       Impact factor: 5.250

5.  (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

Authors:  N G Bowery; D R Hill; A L Hudson; A Doble; D N Middlemiss; J Shaw; M Turnbull
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

6.  GABAB-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex.

Authors:  J A Gray; A R Green
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

7.  The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.

Authors:  G M Goodwin; R J De Souza; A R Green
Journal:  Neuropharmacology       Date:  1985-12       Impact factor: 5.250

8.  Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.

Authors:  G Gianutsos; K E Moore
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

9.  Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors.

Authors:  D J Heal; J Philpot; S G Molyneux; A Metz
Journal:  Neuropharmacology       Date:  1985-12       Impact factor: 5.250

10.  Barbiturate receptor sites are coupled to benzodiazepine receptors.

Authors:  F Leeb-Lundberg; A Snowman; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  15 in total

1.  Changes in rectal temperature and ECoG spectral power of sensorimotor cortex elicited in conscious rabbits by i.c.v. injection of GABA, GABA(A) and GABA(B) agonists and antagonists.

Authors:  Maria Frosini; Massimo Valoti; Giampietro Sgaragli
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

2.  Identification of a G-Protein-Independent Activator of GIRK Channels.

Authors:  Yulin Zhao; Peter Man-Un Ung; Gergely Zahoránszky-Kőhalmi; Alexey V Zakharov; Natalia J Martinez; Anton Simeonov; Ian W Glaaser; Ganesha Rai; Avner Schlessinger; Juan J Marugan; Paul A Slesinger
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

3.  Pharmacological validation of a novel animal model of anticipatory anxiety in mice.

Authors:  A Lecci; F Borsini; G Volterra; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Blunted 5-HT1A receptor-mediated responses and antidepressant-like behavior in mice lacking the GABAB1a but not GABAB1b subunit isoforms.

Authors:  Laura H Jacobson; Daniel Hoyer; Dominique Fehlmann; Bernhard Bettler; Klemens Kaupmann; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2017-01-09       Impact factor: 4.530

5.  GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo.

Authors:  Wouter Koek; Charles P France; Kejun Cheng; Kenner C Rice
Journal:  J Pharmacol Exp Ther       Date:  2010-07-13       Impact factor: 4.030

6.  Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.

Authors:  M Kalinichev; T Donovan-Rodriguez; F Girard; E Riguet; M Rouillier; B Bournique; H Haddouk; V Mutel; S Poli
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

7.  The role of GABAB receptors in mediating the stimulatory effects of ethanol in mice.

Authors:  R E Humeniuk; J M White; J Ong
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains.

Authors:  Laura H Jacobson; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2005-01-25       Impact factor: 4.530

9.  Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice.

Authors:  Christophe Quéva; Marianne Bremner-Danielsen; Anders Edlund; A Jonas Ekstrand; Susanne Elg; Sven Erickson; Thore Johansson; Anders Lehmann; Jan P Mattsson
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

10.  Effects of GABA agonists and antagonists on temperature-sensitive neurones in the rat hypothalamus.

Authors:  K Yakimova; H Sann; H A Schmid; F K Pierau
Journal:  J Physiol       Date:  1996-07-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.